MSC News

MSC News National Headlines Sports Top Headlines CBS US News CBS Technology

Printer Friendly

Email to a Friend

Kobach files suit against Pfizer; cites COVID deception

By Brian Hagen

06/17/2024

Kris Kobach

(MSC News)--Kansas Attorney General Kris Kobach is suing pharmaceutical company Pfizer for what he calls "misleading claims it made related to the COVID vaccine."

According to a release from his office, Kobach and Deputy Attorney General Fran Oleen, Assistant Attorney General Kaley Schrader, and Assistant Attorney General Melanie Jack announced the lawsuit at a press conference held Monday in Topeka.

The release says the complaint was filed Monday in Thomas County District Court, with the complaint alleging that "Pfizer misled Kansans about the vaccines’ risks, including to pregnant women and for myocarditis. Additionally, Pfizer claimed its vaccine protected against COVID variants, despite data showing otherwise. The pharmaceutical giant also suggested its vaccine prevented COVID transmission, but later admitted it had never studied whether its vaccine stopped transmission."

The complaint also alleges that Pfizer coordinated with social media officials to censor speech critical of COVID-19 vaccines and declined to participate in the federal government- vaccine development program, Operation Warp Speed, to avoid government oversight.

Pfizer, on Monday, issued the following statement in regards to the lawsuit.

“We are proud to have developed the COVID-19 vaccine in record time in the midst of a global pandemic and saved countless lives. The representations made by Pfizer about its COVID-19 vaccine have been accurate and science-based. The Company believes that the state- case has no merit and will respond to the suit in due course.

“Pfizer is deeply committed to the well-being of the patients it serves and has no higher priority than ensuring the safety and effectiveness of its treatments and vaccines. Since its initial authorization by FDA in December 2020, the Pfizer-BioNTech COVID-19 vaccine has been administered to more than 1.5 billion people, demonstrated a favorable safety profile in all age groups, and helped protect against severe COVID-19 outcomes, including hospitalization and death.

“Patient safety is our number one priority, which is why we follow diligent safety and monitoring protocols.”

You will need to be logged in to leave a comment.

Please Login

The posting of advertisements, profanity, or personal attacks is prohibited.

Click here to review our Terms of Use.